Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of 4 prognostic indices in follicular lymphoma treated in first line with immunochemotherapy.
Rodríguez-Sevilla JJ, Fernández-Rodríguez C, Bento L, Diez-Feijóo R, Pinzón S, Gibert J, Fernández-Ibarrondo L, Lafuente M, Ferrer A, Sánchez-González B, Gimeno E, Sainz J, Ramos R, García JF, Colomo L, Bellosillo B, Gutiérrez A, Salar A. Rodríguez-Sevilla JJ, et al. Among authors: diez feijoo r. Blood Adv. 2023 Apr 25;7(8):1606-1614. doi: 10.1182/bloodadvances.2022007949. Blood Adv. 2023. PMID: 36260737 Free PMC article.
Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity.
Fernández-Rodríguez C, Rodríguez-Sevilla JJ, Fernández-Ibarrondo L, Sánchez-González B, Gibert J, Bento L, García JF, Sancho JM, Diez-Feijóo R, Camacho L, García-Retortillo M, Gimeno E, Colomo L, Gutiérrez A, Bellosillo B, Salar A. Fernández-Rodríguez C, et al. Among authors: diez feijoo r. Blood Adv. 2022 Jan 11;6(1):82-86. doi: 10.1182/bloodadvances.2021005316. Blood Adv. 2022. PMID: 34649275 Free PMC article.
Evaluation of routine CT scans in the follow-up of diffuse large B-cell lymphomas.
Mascaró-Pol M, Díez-Feijoo R, Rodriguez-Sevilla JJ, Fernández-Rodriguez C, García-Pallarols F, Flores S, Vazquez I, Rodriguez-Lopez S, Roman D, Gimeno E, Colomo L, Maiques J, Sánchez-González B, Salar A. Mascaró-Pol M, et al. Among authors: diez feijoo r. Hematology. 2021 Dec;26(1):709-715. doi: 10.1080/16078454.2021.1975957. Hematology. 2021. PMID: 34547987
T cell lymphoblastic lymphoma with uncommon CD20 expression.
Diez-Feijóo R, Rodríguez-Sevilla JJ, Salido M, Colomo L, Salar A. Diez-Feijóo R, et al. Int J Lab Hematol. 2022 Apr;44(2):234-235. doi: 10.1111/ijlh.13769. Epub 2021 Nov 24. Int J Lab Hematol. 2022. PMID: 34821038
Lack of expression of LMO2 clone SP51 identifies MYC rearrangements in aggressive large B-cell lymphomas.
Vazquez I, Papaleo N, Lop J, Puiggros A, Sanchez-Gonzalez B, Diez-Feijoo R, Gimeno E, Andrade-Campos M, Salar A, Espinet B, Salido M, Tapia G, Carreras J, Ferrer A, Arenillas L, Calvo X, Colomo L. Vazquez I, et al. Among authors: diez feijoo r. Virchows Arch. 2021 Dec;479(6):1073-1078. doi: 10.1007/s00428-021-03091-9. Epub 2021 Apr 3. Virchows Arch. 2021. PMID: 33811533
Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas.
Diez-Feijóo R, Andrade-Campos M, Gibert J, Sánchez-González B, Fernández-Ibarrondo L, Fernández-Rodríguez C, Garcia-Gisbert N, Camacho L, Lafuente M, Vázquez I, Colomo L, Salar A, Bellosillo B. Diez-Feijóo R, et al. Cancers (Basel). 2024 Jan 11;16(2):321. doi: 10.3390/cancers16020321. Cancers (Basel). 2024. PMID: 38254810 Free PMC article.